Literature DB >> 24165949

Drug therapy: smuggling trastuzumab into the brain.

M Teresa Villanueva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24165949     DOI： 10.1038/nrclinonc.2013.202

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Selective permeabilization of the blood-brain barrier at sites of metastasis.

Authors:  John J Connell; Grégoire Chatain; Bart Cornelissen; Katherine A Vallis; Alastair Hamilton; Len Seymour; Daniel C Anthony; Nicola R Sibson
Journal:  J Natl Cancer Inst       Date:  2013-10-09       Impact factor: 13.506
  1 in total
  2 in total

1.  Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.

Authors:  Mohamed Ismail Nounou; Chris E Adkins; Evelina Rubinchik; Tori B Terrell-Hall; Mohamed Afroz; Tim Vitalis; Reinhard Gabathuler; Mei Mei Tian; Paul R Lockman
Journal:  Pharm Res       Date:  2016-08-15       Impact factor: 4.200

2.  Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer.

Authors:  Tori B Terrell-Hall; Mohamed Ismail Nounou; Fatema El-Amrawy; Jessica I G Griffith; Paul R Lockman
Journal:  Oncotarget       Date:  2017-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.